Login / Signup
Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.
Chiara Cattaneo
Roberto Cairoli
Giuseppe Rossi
Published in:
Cancer (2021)
Keyphrases
</>
coronavirus disease
sars cov
chronic myeloid leukemia